What’s New at DCN?

Antibody Selection for Optimal Lateral Flow Assay Development

Antibody Selection for Optimal Lateral Flow Assay Development

The selection of the right antibody is key to creating a robust immunoassay that consistently provides reliable analytical information.

Rapid Pathogen Screening, Inc. wins $10,000 Innovation Award at the Advanced Lateral Flow Course

Rapid Pathogen Screening, Inc. wins $10,000 Innovation Award at the Advanced Lateral Flow Course

DCN Dx and QIAGEN Lake Constance announced today that Rapid Pathogen Screening, Inc. (RPS) was the winner of the first $10,000 Innovation Award at the Advanced Lateral Flow Course. RPS was selected from 38 entrants that described advances in diagnostic technology.

E25Bio and DCN Dx partner for the development of a product for early detection of infectious diseases

E25Bio and DCN Dx partner for the development of a product for early detection of infectious diseases

DCN Dx and E25Bio, an MIT-spinoff diagnostics company from the Gehrke Lab at IMES, have announced a partnership for the design, development and manufacture of an innovative new infectious disease testing technology.

Antibody Labeling and Analyte Detection for Lateral Flow Assays

Antibody Labeling and Analyte Detection for Lateral Flow Assays

Innovative chemistry has developed several antibody labeling materials that can be used to modify antibodies to enhance their detectability. These antibody labeling materials include gold nanoparticles, colored cellulose particles, colored latex particles, magnetic particles, carbon nanoparticles, quantum dots, fluorophores and various enzymes.

DCN Dx Named Top 10 in In-Vitro Diagnostic Technology

DCN Dx Named Top 10 in In-Vitro Diagnostic Technology

DCN Dx has been recognized by Med Tech Outlook Magazine as a top 10 solution provider for in-vitro diagnostic technology for 2018. Read the exclusive article on Brendan O’Farrell, President & Founding Partner of DCN Dx here!

The Case for User-Centric Assay Design

The Case for User-Centric Assay Design

This article highlights the importance of designing a rapid diagnostic test for its intended purpose. Before going into the lab to develop an assay, one must start at the end and correctly identify the goals and use of the product. Only then can a point of care diagnostic device be designed correctly.

DCN Dx Announces First Rapid Testing Innovation Award

DCN Dx Announces First Rapid Testing Innovation Award

DCN Dx, in collaboration with Qiagen Lake Constance, is pleased to announce the first Rapid Testing Innovation Award, to be presented at the 2018 Advanced Lateral Flow Course in October. This competitive prize includes a cash award of $10,000 and will recognize the best innovation in the field of rapid point-of-care assays or the most novel application for rapid assays during the past year.

The Critical Components of Successful Assay Design

The Critical Components of Successful Assay Design

A rapid diagnostic test is a tool that, like any other tool, must be designed and built for its intended purpose. Before going into the lab to develop an assay, one must start at the end and correctly identify the goals and use of the product. Only then can point of care diagnostic products be designed correctly.

DCN Dx & QIAGEN Host the 2018 Advanced Lateral Flow Course

DCN Dx & QIAGEN Host the 2018 Advanced Lateral Flow Course

Registration is open! Join us for this 3-day educational seminar co-hosted by DCN Dx and QIAGEN Lake Constance.  The content of this event is aimed at developers and manufacturers of rapid diagnostic tests and their associated products. 

DCN Dx is Exhibiting at the 2018 American Biomanufacturing Summit

DCN Dx is Exhibiting at the 2018 American Biomanufacturing Summit

Join us at this senior level networking event to discuss strategic insights in manufacturing, outsourcing, capacity management, quality assurance, quality control, regulatory compliance, operational excellence, supply chain and logistics. If you are in the San Francisco area, contact us to schedule a meeting with one of our representatives.

DCN Dx is Sponsoring the 2018 Hands-On Lateral Flow Workshop

DCN Dx is Sponsoring the 2018 Hands-On Lateral Flow Workshop

Make your own working pregnancy test at this 3-day lateral flow workshop co-hosted by BioDot and OPERON. Learn to dispense, laminate, cut and test a rapid diagnostic device. DCN Dx will be participating as a sponsor and also giving educational talks in the main agenda.

DCN Dx is Exhibiting at the 2018 AACC Scientific Meeting

DCN Dx is Exhibiting at the 2018 AACC Scientific Meeting

DCN Dx will be exhibiting at the 2018 AACC Scientific Meeting and Clinical Lab Expo in Chicago, Illinois this July. Stop by booth #3452 to learn about our private lateral flow education and training courses. There is no better way to kick-start your rapid diagnostic test development project.

DCN Dx is Exhibiting at the 2018 ASTMH Annual Meeting

DCN Dx is Exhibiting at the 2018 ASTMH Annual Meeting

DCN Dx will be exhibiting at the 2018 ASTMH educational conference in Louisiana this November. Lateral flow is the ideal format for point of care diagnosis in low resource environments. These devices are inexpensive, robust, easy to transport and user friendly. Meet us at ASTMH to learn more.

DCN Dx 2018 Events Calendar

DCN Dx 2018 Events Calendar

The DCN Dx 2018 events calendar is filling up quickly with a variety of tradeshows, workshops and seminars all over the world. If DCN Dx is coming to your town, let us know and we can set up a meeting to discuss our portfolio of products and services geared towards lateral flow assay developers.

Lateral Flow Rapid Diagnostic Tests: How Does a Lateral Flow Device Work?

Lateral Flow Rapid Diagnostic Tests: How Does a Lateral Flow Device Work?

The lateral flow assay (LFA) is the right solution for many immunoassay applications not appropriate for a central laboratory.
LFAs have advanced from their earlier versions both in terms of detection limits and areas of application. Here, we trace the history of LFAs and provide four examples of their modern applications.

Beyond Pregnancy Tests: Current Applications of Point of Care Diagnostic Testing

Beyond Pregnancy Tests: Current Applications of Point of Care Diagnostic Testing

The lateral flow assay (LFA) is the right solution for many immunoassay applications not appropriate for a central laboratory.
LFAs have advanced from their earlier versions both in terms of detection limits and areas of application. Here, we trace the history of LFAs and provide four examples of their modern applications.

Seven Reasons Why You Should Consider Lateral Flow Technology for Your Next Rapid Test Development Project

Seven Reasons Why You Should Consider Lateral Flow Technology for Your Next Rapid Test Development Project

When you think of modern, user-centric diagnostic technology with high accuracy for tough challenges, you don’t automatically think “lateral flow”. The industry has not done a great job of making you aware of what the technology can do. In this article, DCN Dx discusses how the technology has moved on from what it was 30 years ago.

DCN Dx at SLAS 2018

DCN Dx at SLAS 2018

Members of the DCN Dx team will be walking the exhibit hall. Schedule a time to discuss your lateral flow immunoassay development program at the show or at our facility in Carlsbad.

DCN Dx, Inc. appoints John L. Tonkinson, Ph.D. as Chief Business Development Officer

DCN Dx, Inc. appoints John L. Tonkinson, Ph.D. as Chief Business Development Officer

DCN Dx, Inc., a leading developer of rapid point-of-care diagnostic tests, announced today that John L. Tonkinson, Ph.D. has joined the company in the newly created role of Chief Business...

DCN Charitable Fund Donations 2017

DCN Charitable Fund Donations 2017

As you may know, the core of our mission at DCN is to deliver positive outcomes for our clients and for our broader community. Thanks to your support, this year we have been able to expand our list of charitable contributions to include a variety of organizations.

Part 2: Where Are All the Multiplexed LFI’s?

Part 2: Where Are All the Multiplexed LFI’s?

DCN uses SymbolicsTM to create arrays of spots in the lateral flow field using high precision dispensers.

Out of the Mouths of Babes

Out of the Mouths of Babes

Why there have been no commercial successes in applying cell phone readers to POC, regulated, LFI based diagnostics? Why is there no industry standard for hardware or software specifications? Isn’t it time for that?

DCN Goes Viral!

DCN Goes Viral!

Watch our promo video and stay up to date on lateral flow news by subscribing to our YouTube channel.

Advanced LFI Technology For Point of Care & Field-Based Applications

Advanced LFI Technology For Point of Care & Field-Based Applications

Dr. Brendan O’Farrell has written a new book chapter on the most recent advances in lateral flow technology and their application in point of care applications.

Why Do LFI Cassettes Give Problems?

Why Do LFI Cassettes Give Problems?

The cassette is an essential part of the product. It’s the key to functionality, usability, user satisfaction, and branding and value proposition. This component should not be an afterthought.

Jack of all Trades

Jack of all Trades

There are few places one can learn how to develop LFI’s outside of a few industrial sources like DCN. With this technology there is no substitute for experience when it comes to developing a product that can be manufactured and produced to meet specifications in high volume.

Part 1: Where Are All the Multiplexed LFI’s?

Part 1: Where Are All the Multiplexed LFI’s?

Multiplexing is a growing area of application development. It brings some very specific thought processes along with it when it comes to designing, developing and commercializing products.